Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This nutricosmetic combination was developed by Nestlé and L'Oréal (under the Innéov brand) to enhance skin health and provide photoprotection against ultraviolet (UV) radiation. The formulation centers on the probiotic strain *Lactobacillus paracasei* NCC2461 (also known as ST11), which has been shown in clinical studies to modulate the immune system and reduce UV-induced immunosuppression in the skin. The addition of *Streptococcus thermophilus* and *Lactobacillus delbrueckii* subsp. *bulgaricus* supports the probiotic profile. The supplement also includes a blend of antioxidants—Vitamin C, Vitamin E, and beta-carotene—to neutralize reactive oxygen species generated by sun exposure, alongside B-vitamins (B2 and B3) for skin barrier maintenance and cellular health. The oil component, typically blackcurrant seed oil, provides essential fatty acids to support skin hydration and integrity. The Innéov joint venture was discontinued in 2015, though the research into these components continues within Nestlé's health science portfolio.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lactobacillus paracasei NCC2461 + streptococcus thermophilus + lactobacillus delbrueckii subsp. bulgaricus + vitamin B2 + vitamin B3 + vitamin C + vitamin E + beta-carotene + oil.